骨髄異形成/骨髄増殖性疾患
WordNet
- an impairment of health or a condition of abnormal functioning
PrepTutorEJDIC
- (体の)『病気』,疾患 / (精神・道徳などの)病気,病弊
- 女性の話術芸人 =diseur
UpToDate Contents
全文を閲覧するには購読必要です。 To read the full text you will need to subscribe.
English Journal
- Is survival in myeloid malignancies really improving? A retrospective 15 year population-based study.
- Osca-Gelis G, Puig-Vives M, Saez M, Gallardo D, Lloveras N, Guàrdia R, Marcos-Gragera R.
- Leukemia & lymphoma.Leuk Lymphoma.2014 Jul 24:1-18. [Epub ahead of print]
- Abstract Myeloid malignancies (MMs) are heterogeneous groups of diseases which present different prognoses. Using data from the population-based Girona Cancer Registry, we estimated the relative survival (RS) rates and the relative excess risk of death among patients with MMs in the province of Giro
- PMID 25058372
- Clinical characteristics of 15 children with juvenile myelomonocytic leukaemia who developed blast crisis: MDS Committee of Japanese Society of Paediatric Haematology/Oncology.
- Honda Y1, Tsuchida M, Zaike Y, Masunaga A, Yoshimi A, Kojima S, Ito M, Kikuchi A, Nakahata T, Manabe A.
- British journal of haematology.Br J Haematol.2014 Jun;165(5):682-7. doi: 10.1111/bjh.12796. Epub 2014 Mar 4.
- Juvenile myelomonocytic leukaemia (JMML) is a rare haematopoietic stem cell disease of early childhood, which can progress to blast crisis in some children. A total of 153 children diagnosed with JMML were reported to the Myelodysplastic Syndrome Committee in Japan between 1989 and 2007; 15 of them
- PMID 24588411
- Expression of PD-L1, PD-L2, PD-1 and CTLA4 in myelodysplastic syndromes is enhanced by treatment with hypomethylating agents.
- Yang H1, Bueso-Ramos C2, DiNardo C1, Estecio MR3, Davanlou M2, Geng QR4, Fang Z1, Nguyen M2, Pierce S1, Wei Y1, Parmar S5, Cortes J1, Kantarjian H1, Garcia-Manero G1.
- Leukemia.Leukemia.2014 Jun;28(6):1280-8. doi: 10.1038/leu.2013.355. Epub 2013 Nov 25.
- Blockade of immune checkpoints is emerging as a new form of anticancer therapy. We studied the expression of programmed death ligand 1 (PD-L1), PD-L2, programmed death 1 (PD-1) and cytotoxic T lymphocyte-associated antigen 4 (CTLA4) mRNA in CD34+ cells from myelodysplastic syndrome (MDS), chronic my
- PMID 24270737
Japanese Journal
- WHO分類における新しい疾患群MDS/MPDの臨床像
- 福原 敬,柿木 康孝
- 臨床病理 = THE OFFICIAL JOURNAL OF JAPANESE SOCIETY OF LABORATORY MEDICINE 54(3), 243-249, 2006-03-20
- NAID 10019249414
- フィラデルフィア染色体陰性骨髄異形成症候群/骨髄増殖性疾患の3症例
- 田中 芳紀,松井 久末子,櫻木 志津 [他],三谷 紀之,松田 万幸,篠原 健次
- 山口医学 54(5), 139-145, 2005-10-31
- … WHO分類により骨髄異形成症候群/骨髄増殖性疾患myelodysplastic/myeloproliferative diseases (MDS)/(MPD)に分類されるPhiladelphia (Ph)染色体陰性の非定型慢性骨髄性白血病atypical CML (aCML) 2例と慢性骨髄単球性白血病chronic myelomonocytic leukemia (CMML) 1例を経験した.aCMLの2症例は白血球増加, 各成熟段階の顆粒球系細胞の増加, 顆粒球の異形成を認めたが染色体異常は認めなかった.CA (cytosine arabinoside, …
- NAID 110002774491
Related Links
- Myelodysplastic/myeloproliferative disease, unclassifiable (MDS/MPD, U) General · Cases with clinical, laboratory and morphologic features that support a diagnosis of both MDS and MPD, but do not meet criteria for other entities ...
- Myelodysplastic/myeloproliferative diseases are a group of diseases of the blood and bone marrow in which the bone marrow makes too many white blood cells. These disease have features of both myelodysplastic ...
★リンクテーブル★
[★]
- 英
- myelodysplastic/myeloproliferative diseases, MDS/MPD
- 関
- MDS, MPD
[★]
- 疾患：illnessより厳密な概念。「ある臓器に明確な障害が確認され、それによって症状が出ているとはっきり説明できる場合」 (PSY.9)
- 特定の原因、病態生理、症状、経過、予後、病理組織所見が全てそろった場合 (PSY.9)
- something that is very wrong with people's attitudes, way of life or with society.
- 関
- ail、ailment、disease entity、disorder、ill、illness、malady、sick、sickness
- disease ≠ illness ≠ disorder
[★]
- 関
- marrow dysplasia